LCMC Health Holdings INC

LCMC Health Holdings INC was paid $11.38M by Medicaid between Jan 2018 and Dec 2022, across 111 billing codes. Its largest line is 99284, emergency room visit (serious) — 21% of everything it billed.

33Billing provider infoLCMC HEALTH HOLDINGS INC
METAIRIE, LA 70006

33aNPI1538174347assigned 07/30/2006

33bProvider typePsychiatric Hospital Unit

28Total paid$11.38M

24GClaims242,642

24DCodes billed111

24AFirst – last monthJan 2018 – Dec 2022

Compared with peers

Next to other Psychiatric Hospital Unit providers in Louisiana

Rank by total paid#3 of 7

Median peer was paid$3.63M

This provider vs. median3.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	48,880	$2.15M
2019	46,435	$2.01M
2020	33,280	$1.52M
2021	47,403	$2.17M
2022	66,644	$3.53M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	21%	18,352	16,147	$2.39M
A0427	Emergency ambulance ride, advanced life supportAmbulance service, advanced life support, emergency transport, level 1 (als 1 - emergency)	18%	18,554	13,599	$2.10M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	15,636	14,090	$1.67M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	9.2%	6,968	6,039	$1.05M
A0429	Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency)	6.1%	10,636	7,817	$697K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	4.9%	17,190	15,425	$562K
A0425	Ground mileage, per statute mile	3.6%	29,469	21,906	$406K
76819	Fetal biophysical profile; without non-stress testing	3.0%	3,088	2,309	$343K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	2.4%	11,561	9,779	$268K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	2.3%	3,067	2,334	$262K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	1.8%	7,788	6,750	$203K
80053	Comprehensive metabolic panel	1.2%	21,989	18,700	$140K

99 more codes

11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.1%	1,107	$130K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	1,105	$114K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	2,928	$105K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	21,914	$101K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	3,832	$89K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	2,676	$82K
71045	Radiologic examination, chest; single view	<1%	3,666	$66K
96375	Therapeutic injection; each additional sequential IV push	<1%	1,990	$64K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	1,395	$43K
70450	Computed tomography, head or brain; without contrast material	<1%	364	$39K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	1,132	$35K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	1,124	$35K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,824	$34K
99214	Doctor's office visit, returning patient (more involved)	<1%	745	$34K
71046	Radiologic examination, chest; 2 views	<1%	1,289	$31K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	277	$31K
96361	Intravenous infusion, hydration; each additional hour	<1%	1,035	$23K
64721		<1%	82	$22K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	675	$20K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	633	$18K
36415	Collection of venous blood by venipuncture	<1%	8,251	$15K
84484		<1%	1,904	$13K
76820		<1%	183	$13K
84703		<1%	1,831	$11K
59025	Fetal non-stress test	<1%	127	$11K
0002A		<1%	697	$10K
0001A		<1%	588	$8K
J7030	Infusion, normal saline solution , 1000 cc	<1%	1,718	$8K
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	12	$7K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	62	$7K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	89	$6K
81001		<1%	2,826	$6K
88142		<1%	497	$6K
99203	Doctor's office visit, new patient (routine)	<1%	127	$4K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	58	$4K
83690		<1%	834	$4K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	138	$3K
83735		<1%	908	$3K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	1,211	$3K
83880		<1%	130	$3K
81025		<1%	502	$3K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	31	$3K
86140		<1%	735	$2K
A0433	Advanced life support, level 2 (als 2)	<1%	13	$2K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	12	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	151	$2K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	125	$2K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	29	$1K
0003A		<1%	40	$1K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	800	$1K
87086	Culture, bacterial; quantitative colony count, urine	<1%	179	$1K
84443	Thyroid stimulating hormone (TSH)	<1%	90	$1K
84702		<1%	84	$958.74
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	14	$823.90
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	111	$822.83
97161		<1%	14	$714.36
80061	Lipid panel	<1%	57	$602.55
80305		<1%	61	$568.68
82550		<1%	117	$498.66
J2270	Injection, morphine sulfate, up to 10 mg	<1%	284	$493.44
74018		<1%	14	$461.04
G0378	Hospital observation service, per hour	<1%	31	$455.13
81003		<1%	255	$372.33
80050	General health panel	<1%	15	$364.32
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	23	$346.56
80048	Basic metabolic panel (calcium, ionized)	<1%	68	$253.80
80320		<1%	49	$228.82
80329		<1%	15	$210.45
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	13	$171.33
85730		<1%	80	$158.57
A0998	Ambulance response and treatment, no transport	<1%	59	$155.00
J1170	Injection, hydromorphone, up to 4 mg	<1%	85	$154.61
J7120	Ringers lactate infusion, up to 1000 cc	<1%	26	$152.82
85027		<1%	44	$135.87
85610		<1%	78	$114.26
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	14	$110.29
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	14	$48.50
J3490	Unclassified drugs	<1%	42	$40.31
81002		<1%	15	$39.36
83615		<1%	14	$30.30
94760		<1%	16	$28.91
J2704	Injection, propofol, 10 mg	<1%	557	$17.33
86850		<1%	18	$13.48
84100		<1%	18	$9.48
86900		<1%	18	$5.98
86901		<1%	18	$5.98
91300		<1%	761	$0.27
01810		0%	116	$0.00
99001		0%	20	$0.00
J3370	Injection, vancomycin hcl, 500 mg	0%	24	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	19	$0.00
87631		0%	12	$0.00
88342		0%	13	$0.00
J3010	Injection, fentanyl citrate, 0.1 mg	0%	117	$0.00
A4648	Tissue marker, implantable, any type, each	0%	45	$0.00
J0690	Injection, cefazolin sodium, 500 mg	0%	18	$0.00
J2250	Injection, midazolam hydrochloride, per 1 mg	0%	89	$0.00
G0463	Hospital outpatient clinic visit for assessment and management of a patient	0%	45	$0.00
88305	Level IV - Surgical pathology, gross and microscopic examination	0%	33	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCALISTER, JENNY (DIRECTOR)